Biosciences Division

News

  • New ORNL process brings nanoparticles into focus

    Scientists can study the biological impacts of engineered nanomaterials on cells within the body with greater resolution than ever because of a procedure developed by researchers at the Department of Energy's Oak Ridge National Laboratory.

  • Audio Spot: New medicine therapeutics company is spinout from ORNL

    A Company, NellOne Therapeutics, has been formed through Battelle Ventures to research the potential for a new therapy that could help heart patients, according to Oak Ridge National Laboratory scientist Cymbeline Culiat.

Nanoscale Science & Devices Group

Understanding the physics and chemistry at the nanoscale is important in designing and developing miniature sensors and devices that exploit nanoscale effects.

By doing so, we build the foundation of an exciting convergence of many traditionally separate fields of science. Once-distinct boundaries between molecular biology, fluid mechanics, quantum mechanics and photonics are crossed. The resulting technological advancements have the possibility to benefit every human being; from improved detection and treatment of cancers, detecting landmines, artifically restoring the sight and hearing of the visually and aurally impaired to protecting civilians and armed forces personnel from conventional explosive weapons and NBC (nuclear, biological, chemical) weapons.

Further details are on the website. http://nanoscale.ornl.gov/

Contact: Thomas G. Thundat (Please direct all email enquiries to Cathy Gaudreau gaudreaucl@ornl.gov, 865-574-6232